BrightSpring Health CEO Rousseau sells $11.57 million in stock

Published 13/06/2025, 21:08
BrightSpring Health CEO Rousseau sells $11.57 million in stock

Jon B. Rousseau, Chairman, President, and CEO of BrightSpring Health Services, Inc. (NASDAQ:BTSG), a prominent player in the Healthcare Providers & Services industry with annual revenue of $11.9 billion, recently sold a significant portion of company stock, according to a recent filing. The transaction comes as InvestingPro data shows the stock has experienced a 10.4% decline over the past week, despite maintaining a remarkable 103% gain over the last year. On June 12, 2025, Rousseau sold 531,840 shares of BrightSpring common stock at a price of $21.75 per share, totaling approximately $11.57 million. This sale was part of a registered public offering.

The transaction also included the exercise of stock options, where Rousseau acquired 531,840 shares at a price of $6.37 per share, amounting to a total acquisition value of $3,387,820. Following these transactions, Rousseau holds 1,184,133 shares directly.

In addition to his direct holdings, Rousseau maintains indirect ownership through family trusts, although he disclaims beneficial ownership of these shares except to the extent of his pecuniary interest. The company currently trades at a P/E ratio of 88.6x, though InvestingPro analysis indicates it’s trading at a low revenue valuation multiple relative to peers.

In other recent news, BrightSpring Health Services reported a strong start to 2025 with a 26% year-over-year increase in total revenue, reaching $2.9 billion for the first quarter. Despite this robust revenue growth, the company’s earnings per share (EPS) of $0.19 slightly missed the forecasted $0.20. The Pharmacy Solutions segment was a major contributor, generating $2.5 billion in revenue, a 28% increase from the previous year. In related developments, Mizuho (NYSE:MFG) Securities raised its price target for BrightSpring Health to $26, maintaining an Outperform rating, citing the company’s strong performance and strategic positioning.

Additionally, BrightSpring announced that certain stockholders, including affiliates of Kohlberg Kravis Roberts & Co. L.P., plan to sell 14 million shares in a secondary offering. The company will not receive any proceeds from this transaction. Meanwhile, the results of BrightSpring’s annual meeting confirmed the election of two Class I directors and the appointment of KPMG LLP as the independent registered public accounting firm for the fiscal year. These moves align with the company’s strategic initiatives and governance practices.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.